Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
33 pending office actions • 27 art units • 31 examiners • 0 of 33 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Trustees of Tufts College has 34 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 32 distinct examiners across 27 distinct art units, indicating that prosecution is distributed across many biotechnology and pharmaceutical examination groups.
LIPPERT, JOHN WILLIAM is the busiest examiner, with 2 pending matters. Centralized tracking and consistent scientific positions can support management, but each application requires analysis tailored to its examiner and art-unit assignment.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (18%) |
| §102 only | 1 (3%) |
| §112 only | 4 (12%) |
| Double-patenting + other | 5 (15%) |
| Multi-statute (no §101) | 17 (52%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIPPERT, JOHN WILLIAM | 2 | 59.2% | +39.9% |
| PETERS, ALEC JON | 2 | 67.4% | +54.8% |
| OUSPENSKI, ILIA I | 1 | 77.3% | +20.6% |
| SHENG, CHAO | 1 | 65.0% | +26.6% |
| MUKHOPADHYAY, BHASKAR | 1 | 28.2% | +37.0% |
| MULVANEY, ELIZABETH EVANS | 1 | 78.8% | +15.3% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
| BROPHY, MATTHEW J | 1 | 68.5% | +34.3% |
| ALLEY, GENEVIEVE S | 1 | 60.5% | +48.3% |
| CORNET, JEAN P | 1 | 41.9% | +47.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274010 | Thread-Based Transistors | KIELIN, ERIK J | 155d overdue |
| 17778482 | DIRECTED CHANGES IN ORGANISM POPULATIONS | PENNINGTON, KATIE LEIGH | 17d overdue |
| 18342271 | SILK-BASED ARTICLES HAVING DECREASED WATER UPTAKE AND IMPROVED MECHANICAL PROPERTIES, AND METHODS OF MAKING AND USING THE SAME | JOHNSON, JENNA LEIGH | 15d |
| 18034221 | ENZYME-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | PETERS, ALEC JON | 39d |
| 19292322 | ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF | OUSPENSKI, ILIA I | — |
| 19150269 | DEVICES AND METHODS FOR FREEHAND MULTIMODALITY IMAGING | SHENG, CHAO | — |
| 18875537 | IN VITRO INSECT FAT CULTIVATION FOR CELLULAR AGRICULTURE APPLICATIONS | MUKHOPADHYAY, BHASKAR | — |
| 18966464 | MICROPATTERNED SILK-DOPAMINE ADHESIVES COMPOSITE | MULVANEY, ELIZABETH EVANS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034225 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | PETERS, ALEC JON | 34d |
| 18034221 | ENZYME-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | PETERS, ALEC JON | 39d |
| 19292322 | ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF | OUSPENSKI, ILIA I | — |
| 19150269 | DEVICES AND METHODS FOR FREEHAND MULTIMODALITY IMAGING | SHENG, CHAO | — |
| 18875537 | IN VITRO INSECT FAT CULTIVATION FOR CELLULAR AGRICULTURE APPLICATIONS | MUKHOPADHYAY, BHASKAR | — |
| 18966464 | MICROPATTERNED SILK-DOPAMINE ADHESIVES COMPOSITE | MULVANEY, ELIZABETH EVANS | — |
| 18804673 | METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT HETEROMULTIMERIC NEUTRALIZING BINDING PROTEIN | DEVI, SARVAMANGALA | — |
| 18766092 | FIXED FUNCTION SHARED ACCELERATOR | BROPHY, MATTHEW J | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1615 | 2 |
| 1631 | 2 |
| 1618 | 2 |
| 3791 | 2 |
| 1641 | 2 |
| 1644 | 1 |
| 3797 | 1 |
| 1792 | 1 |
| 1785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19292322 | ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF | OUSPENSKI, ILIA I | 1644 | §102§103§112 | Non-Final OA | — | Pending | Aug 06, 2025 |
| 19150269 | DEVICES AND METHODS FOR FREEHAND MULTIMODALITY IMAGING | SHENG, CHAO | 3797 | §103§112 | Non-Final OA | — | Pending | Jul 23, 2025 |
| 18875537 | IN VITRO INSECT FAT CULTIVATION FOR CELLULAR AGRICULTURE APPLICATIONS | MUKHOPADHYAY, BHASKAR | 1792 | §103 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18966464 | MICROPATTERNED SILK-DOPAMINE ADHESIVES COMPOSITE | MULVANEY, ELIZABETH EVANS | 1785 | §103§112 | Non-Final OA | — | Pending | Dec 03, 2024 |
| 18804673 | METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT HETEROMULTIMERIC NEUTRALIZING BINDING PROTEIN | DEVI, SARVAMANGALA | 1645 | §102§112DP | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18766092 | FIXED FUNCTION SHARED ACCELERATOR | BROPHY, MATTHEW J | 2191 | §103 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18746604 | SILK-BASED ARTICLES HAVING VARIABLE ACTIVE AGENT RELEASE RATES | ALLEY, GENEVIEVE S | 1617 | §112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18719825 | USE OF HYPERPOLARIZING AGENTS ALONE AND IN COMBINATION WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCERS INCLUDING GLIOBLASTOMA | CORNET, JEAN P | 1628 | §112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18705119 | ARTICLES AND METHODS FOR PLASMA SEPARATION | BASS, DIRK R | 1779 | §102§103 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18703626 | KITS, ARTICLES, AND METHODS FOR BLOOD SEPARATION | DRODGE, JOSEPH W | 1778 | §103§112 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18684986 | AMPHIPHILIC POLYAMPHOLYTES AND RELATED MEMBRANES | LEE, RIP A | 1762 | §102§112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18683663 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | LIPPERT, JOHN WILLIAM | 1615 | §103 | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18294033 | CULTURED ADIPOSE TISSUE | GRABER, JAMES J | 1631 | §102§103 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18536002 | IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF | PECKHAM, RICHARD GRANT | 1627 | §102§112 | Final Rejection | — | Pending | Dec 11, 2023 |
| 18513092 | AMINOACYL TRANSFER RNA SYNTHETASES | BREEN, KIMBERLY CATHERINE | 1651 | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18288484 | LIPIDOID NANOPARTICLES FOR THE TREATMENT OF DISEASES AND DISORDERS | LIPPERT, JOHN WILLIAM | 1615 | §103 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18283391 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | DONOHUE, SEAN R | 1618 | §103§112DP | Final Rejection | — | Pending | Sep 21, 2023 |
| 18274010 | Thread-Based Transistors | KIELIN, ERIK J | 2814 | §102§103 | Non-Final OA | 155d overdue | Pending | Jul 25, 2023 |
| 18271135 | FABRICATION TECHNIQUE FOR HYDROGEL FILMS CONTAINING MICROPATTERNED OPAL STRUCTURES | MOUDOU, EILEEN QI-YUN | 1738 | §103§112 | Final Rejection | — | Pending | Jul 06, 2023 |
| 18342271 | SILK-BASED ARTICLES HAVING DECREASED WATER UPTAKE AND IMPROVED MECHANICAL PROPERTIES, AND METHODS OF MAKING AND USING THE SAME | JOHNSON, JENNA LEIGH | 1789 | §102§103§112 | Final Rejection | 15d | Pending | Jun 27, 2023 |
| 18265561 | LIPIDOID COMPOSITIONS AND METHODS OF USE THEREOF | KAMM, JUDITH MARIE | 1637 | §103§112DP | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18205096 | LIPID-LIKE NANOCOMPLEXES AND USES THEREOF | ANTHOPOLOS, PETER | 1611 | §103Other | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18254929 | ENGINEERED MULTICELLULAR ORGANISMS | KIM, TAEYOON | 1631 | §102§103§112 | Non-Final OA | — | Pending | May 30, 2023 |
| 18037430 | Spatially-Selective Sampling of Gut Microbiome | YOON, CHANEL J | 3791 | §102§103§112 | Non-Final OA | — | Pending | May 17, 2023 |
| 18034221 | ENZYME-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | PETERS, ALEC JON | 1641 | §103§112Other | Final Rejection | 39d | Pending | Apr 27, 2023 |
| 18034225 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | PETERS, ALEC JON | 1641 | §103§112DP | Final Rejection | 34d | Pending | Apr 27, 2023 |
| 18162137 | ANTIPHOSPHOLIPID ANTIBODIES FOR THE DIAGNOSIS OF LYME DISEASE | MORGAN, BAILEY MICHELLE | 1645 | §112 | Final Rejection | — | Pending | Jan 31, 2023 |
| 17904690 | METHODS FOR ENGINEERING AMINO ACID AMMONIA LYASE ENZYMES AND ENZYMES THEREBY OBTAINED | IANNUZO, NATALIE NMN | 1653 | §103 | Final Rejection | 19d | Pending | Aug 19, 2022 |
| 17798344 | ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION AND INFLAMMATION | HUANG, GIGI GEORGIANA | 1613 | §102§103 | Final Rejection | — | Pending | Aug 09, 2022 |
| 17838891 | SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERY | DAVIS, BRIAN J | 1614 | §102 | Non-Final OA | 24d overdue | Pending | Jun 13, 2022 |
| 17778482 | DIRECTED CHANGES IN ORGANISM POPULATIONS | PENNINGTON, KATIE LEIGH | 1634 | §102§103§112Other | Non-Final OA | 17d overdue | Pending | May 20, 2022 |
| 17753312 | SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING AND ANALYSIS OF DRUG DELIVERY SYSTEMS IN VITRO | WESTERBERG, NISSA M | 1618 | §103§112DP | Final Rejection | 19d overdue | Pending | Feb 28, 2022 |
| 16979957 | Acquisition of Samples for Evaluating Bacterial Demographics | BLOCH, MICHAEL RYAN | 3791 | §112 | Final Rejection | 36d overdue | Pending | Sep 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTrustees of Tufts College has 33 pending office actions as of October 2026, spread across 27 art units and 31 examiners.
John William Lippert has the most, with 2 of Trustees of Tufts College's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
